Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Cash from Financing Activities (2016 - 2025)

Amphastar Pharmaceuticals has reported Cash from Financing Activities over the past 13 years, most recently at -$18.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$18.4 million for Q4 2025, up 45.71% from a year ago — trailing twelve months through Dec 2025 was -$67.4 million (up 16.71% YoY), and the annual figure for FY2025 was -$67.4 million, up 16.71%.
  • Cash from Financing Activities for Q4 2025 was -$18.4 million at Amphastar Pharmaceuticals, down from -$4.3 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AMPH hit a ceiling of $428.1 million in Q2 2023 and a floor of -$47.1 million in Q4 2023.
  • Median Cash from Financing Activities over the past 5 years was -$13.6 million (2023), compared with a mean of $12.1 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 3730.84% in 2021 and later soared 43169.52% in 2023.
  • Amphastar Pharmaceuticals' Cash from Financing Activities stood at -$8.7 million in 2021, then crashed by 85.86% to -$16.2 million in 2022, then crashed by 191.32% to -$47.1 million in 2023, then grew by 28.12% to -$33.8 million in 2024, then surged by 45.71% to -$18.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$18.4 million (Q4 2025), -$4.3 million (Q3 2025), and -$30.2 million (Q2 2025) per Business Quant data.